Beijing Yierkang Bioengineering

Liaoyuan, China Founded: 1997 • Age: 29 yrs Acquired By Bloomage Biotechnology
Manufacturer of artificial bone and collagen sponge

About Beijing Yierkang Bioengineering

Beijing Yierkang Bioengineering is a Healthcare company based in Liaoyuan (China) founded in 1997, and was acquired by Bloomage Biotechnology in April 2022. Manufacturer of artificial bone and collagen sponge. Its focus areas include Traditional Medical Devices.

Company details

Beijing Yierkang Bioengineering was founded in 1997 in Liaoyuan, China. Focus is placed on bioengineering within the medical materials sector, where artificial bone and collagen sponge are produced. Operations involve research, development, and manufacturing of these biomaterials for orthopedic and wound care applications. Products are distributed primarily in domestic markets, with emphasis on quality standards in healthcare supply chains. The companys domain, bjyek.com, supports information dissemination.

  • Headquarters Liaoyuan, China
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website bjyek.com
  • Acquired by Bloomage Biotechnology (Apr 2022)
Key Metrics

Investors in Beijing Yierkang Bioengineering

Beijing Yierkang Bioengineering has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Bloomage Biotechnology.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Manufacturer of hyaluronic acid & pharmaceutical products
1998bloomagebioactive.comJinan, China
Premium access

Investor details for Beijing Yierkang Bioengineering

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Beijing Yierkang Bioengineering

2 dated milestones of Beijing Yierkang Bioengineering across 25 years, from founding to its latest funding, stage changes and deals.

  1. Founded Beijing Yierkang Bioengineering is founded.
  2. Exit Acquired by Bloomage Biotechnology.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Beijing Yierkang Bioengineering

Beijing Yierkang Bioengineering was founded in 1997.

Beijing Yierkang Bioengineering is headquartered in Liaoyuan, China. It is registered at Liaoyuan, Jilin, China.

Beijing Yierkang Bioengineering was founded in 1997 in Liaoyuan, China. Focus is placed on bioengineering within the medical materials sector, where artificial bone and collagen sponge are produced. Operations involve research, development, and manufacturing of these biomaterials for orthopedic and wound care applications. Products are distributed primarily in domestic markets, with emphasis on quality standards in healthcare supply chains. The companys domain, bjyek.com, supports information dissemination.

Beijing Yierkang Bioengineering has 1 investor. Key investors include Bloomage Biotechnology.

Yes. Beijing Yierkang Bioengineering was acquired by Bloomage Biotechnology in April 2022.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available